2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Respiratory Distress Syndrome in 2 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Luteolin (Lut) was recently identified as the major active ingredient of Mosla scabra, which was a typical representative traditional Chinese medicine and had been used to treat pulmonary diseases for thousands of years." | 5.72 | Luteolin attenuates lipopolysaccharide-induced acute lung injury/acute respiratory distress syndrome by activating alveolar epithelial sodium channels via cGMP/PI3K pathway. ( Cui, Y; Ding, Y; Hou, Y; Li, J; Nie, H, 2022) |
| "Luteolin (Lut) was recently identified as the major active ingredient of Mosla scabra, which was a typical representative traditional Chinese medicine and had been used to treat pulmonary diseases for thousands of years." | 1.72 | Luteolin attenuates lipopolysaccharide-induced acute lung injury/acute respiratory distress syndrome by activating alveolar epithelial sodium channels via cGMP/PI3K pathway. ( Cui, Y; Ding, Y; Hou, Y; Li, J; Nie, H, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, Y | 1 |
| Li, J | 1 |
| Ding, Y | 1 |
| Cui, Y | 1 |
| Nie, H | 1 |
| Uhlig, U | 1 |
| Fehrenbach, H | 1 |
| Lachmann, RA | 1 |
| Goldmann, T | 1 |
| Lachmann, B | 1 |
| Vollmer, E | 1 |
| Uhlig, S | 1 |
2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Luteolin attenuates lipopolysaccharide-induced acute lung injury/acute respiratory distress syndrome by activating alveolar epithelial sodium channels via cGMP/PI3K pathway.
Topics: Alveolar Epithelial Cells; Animals; Chromones; Cyclic GMP; Gene Expression Regulation; Lipopolysacch | 2022 |
Phosphoinositide 3-OH kinase inhibition prevents ventilation-induced lung cell activation.
Topics: Animals; Chemokine CXCL2; Chromones; Enzyme Activation; In Vitro Techniques; Inflammation Mediators; | 2004 |